What is the drug Nilotinib?

Nilotinib is a selective tyrosine kinase inhibitor. Nilotinib is medication to treat blood cancer and, more precisely, patients with Philadelphia chromosome-positive chronic myelogenous leukemia. The nilotinib drug is usually used when other treatments have failed; it is to overcome Imatinib when patients are resistant to this drug. Nilotinib is a second-generation tyrosine kinase inhibitor. Due to its rare use, Nilotinib is considered an “orphan medicine.”

Nilotinib wholesalers and manufacturers:

Novartis manufactures Nilotinib under the name Tasigna. Novartis is also the marketing authorization holder.

Nilotinib for sales:

The retail prices of Nilotinib depend on the dosage of the capsule. In the US, for a 50 mg capsule, Nilotinib costs around $ 137 per unit, it equals to $ 16,470 for 120 capsules. For 150 mg and 200 mg, one Nilotinib capsule costs $ 137, and for 28 capsules, it costs $ 3,850.

How to use Nilotinib drug?

Depending on the phase the patient is in, the Nilotinib dosage will be adjusted. For a newly diagnosed patient, the usual dose for an adult is 300 mg taken twice a day. For a resistant patient, the prescription for an adult is 400 mg taken twice a day. In both cases, Nilotinib drugs must be taken orally within 12 hours in between the two doses. It is better to take Nilotinib medication on an empty stomach; it means no food 2 hours before taking the drug and 1 hour after taking it. It must be stored at room temperature, away from heat, moisture, and direct light.